"There should be some policy. But I don't find any policy. We can't allow them (critically ill patients) to die for want of money. State will have to do something. It can't be a bystander," Justice Manmohan said.
"You can't say human life is not worth preserving. What is the point of having a Constitution if only the rich and mighty get the benefits? We can't have such lofty ideals in the Constitution and not implement the same," the court said.
It made the observation while hearing two pleas, one seeking treatment for a rickshawpuller's minor son who is suffering from Gaucher, a degenerative genetic disorder, and another petition of a bed-ridden haemophiliac man who is pleading to be treated at state expense as his family has run out of money.
While the minor boy requires a monthly dose of enzyme replacement therapy (ERT) costing Rs 4-5 lakh each time, the haemophiliac patient's regular treatment costs Rs one lakh every day and the drug to reduce his rate of bleeding would cost about Rs 75 lakh for a 6-8 weeks treatment.
The court suggested to the Health Secretary of Delhi government, who was present pursuant to its earlier order, to frame a policy or take some decision as he would be the "lead person" in the department and the only person he will have to speak to is the Lt Governor.
"You are the lead person. You are the government now. There is no one in between to interfere with your decision. All you have to do is speak to the LG. So go get it done. You come up with the policy. It will be implemented. There is no one to stop you. You are the sole repository of power. You please do it," the court said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
